12th European AIDS Conference / EACS
WELCOME MESSAGE LIST OF PRESENTATIONS/COURSES OTHER WEBCASTS
Webcasted Presentation
BROWSE: ALL PRESENTATIONS/COURSES SPEAKERS PPT SLIDES VIDEO PODCASTS

Search’n Build™

Non-inferior efficacy shown across different efficacy endpoints in the MONET trial of darunavir/ritonavir (DRV/r) monotherapy

Dr. Diego Ripamonti
Dr. Diego Ripamonti
[Biography]
Italy  
Disclosure : I have received speaker fees from BMS, Abbott and Boheringer
[More] [Less]
PRESENTATION
17 slide(s) – 00:12:28 – English – 2009-11-12
Extra Features Available

VIDEO PODCAST

SLIDE LIBRARY
Learning Objectives
Rate & Comment
A A A  
- Darunavir/r monotherapy vs triple therapy
- Non-inferiority trial and sensitivity analysis
- Downstream consequences of PI-monotherapy failure
A A A  
Rate: Not useful Somewhat useful Mostly useful Useful Very useful

Please let us know how useful this content was for you
and feel free to write your comments below.